Oxaliplatin prior to PARP inhibitor in BRCA-mutated ovarian cancer.
Nicoletto MO, Baldoni A, Cavallin F, Grego A, Falci C, Nardin M, Mammano E, Lai E, Torri V.
Nicoletto MO, et al. Among authors: grego a.
Ther Adv Med Oncol. 2023 Jun 21;15:17588359231173181. doi: 10.1177/17588359231173181. eCollection 2023.
Ther Adv Med Oncol. 2023.
PMID: 37360767
Free PMC article.